1. Review current guidelines for treatment of Muscle Invasive Bladder Cancer (MIBC).

2. Discuss clinical evidence of immunotherapy in the adjuvant setting.

3. Discuss current and future investigational approaches with immunotherapy in the neoadjuvant setting.

Session date: 
12/13/2018 - 8:00am to 9:00am CST
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Carolina Soto Chervin, MD, PhD